BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1974553)

  • 21. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States.
    Deitiker PR; Oshima M; Smith RG; Mosier D; Atassi MZ
    Int J Immunogenet; 2011 Feb; 38(1):55-62. PubMed ID: 21108743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DQ RFLP variants of five HLA-DQw2-bearing major histocompatibility complex extended haplotypes.
    Yunis JJ; Wescott M; Lechin SJ; Alosco SM; Awdeh Z; Alper CA; Yunis EJ
    Immunogenetics; 1990; 32(2):88-95. PubMed ID: 1975800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel TaqI/DQA RFLP associated with HLA-DR9, DQ9 (DQA1*0302).
    Vilches C; de Pablo R; Solís R; Martín R; Herrero MJ; Moreno ME; Kreisler M
    Eur J Immunogenet; 1995 Jun; 22(3):261-4. PubMed ID: 8547232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended HLA-DQw2 haplotypes: molecular analysis.
    Avoustin PA; Tkaczuk J; Coppin HL; Cambon-Thomsen A; de Préval C
    Eur J Immunogenet; 1991 Aug; 18(4):247-57. PubMed ID: 1684911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes.
    Mangklabruks A; Cox N; DeGroot LJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):236-44. PubMed ID: 1677360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restriction fragment length polymorphism of HLA and non-HLA genes in DR3/4 heterozygous Danish insulin-dependent diabetic patients and healthy individuals: reassessment of the influence of alpha DX and insulin-linked polymorphic loci, and new splits of DQw3 haplotypes.
    Zerbib A; Mølvig J; Thomsen M; Coppin H; Cambon-Thomsen A; Sommer E; Nerup J; De Preval C
    Dis Markers; 1989; 7(1):27-41. PubMed ID: 2565778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan.
    Shinomiya N; Nomura Y; Segawa M
    Clin Immunol; 2004 Feb; 110(2):154-8. PubMed ID: 15003812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of HLA-DR/DQ polymorphism with myasthenia gravis in Tunisian patients.
    Fekih-Mrissa N; Klai S; Zaouali J; Gritli N; Mrissa R
    Clin Neurol Neurosurg; 2013 Jan; 115(1):32-6. PubMed ID: 22521184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5.
    Bartoccioni E; Scuderi F; Augugliaro A; Chiatamone Ranieri S; Sauchelli D; Alboino P; Marino M; Evoli A
    Neurology; 2009 Jan; 72(2):195-7. PubMed ID: 19139372
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese.
    Chen WH; Chiu HC; Hseih RP
    J Neurol Neurosurg Psychiatry; 1993 Apr; 56(4):382-5. PubMed ID: 8482958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unusual HLA-DR/DQ haplotypes: two different breakpoints in two different DR2-DQw3 haplotypes.
    Andreas A; Chandanayingyong D; Attatippaholkun W; Sirikong M; Klaythong R; Keller E; Albert ED
    Immunogenetics; 1989; 30(2):141-4. PubMed ID: 2569444
    [No Abstract]   [Full Text] [Related]  

  • 33. A division of HLA-DQw1 associated with DR1, DR1x-DQw1, DR2 short, DRw10, and DRw14. I. Definition by alloantiserum LY 1327.
    Gebuhrer L; Betuel H; Lambert J; Freidel AC; Farre A
    Hum Immunol; 1987 Mar; 18(3):235-45. PubMed ID: 2437088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between HLA-DRB1 and DQ alleles and the genetic susceptibility to type 1 diabetes.
    Sang Y; Yan C; Zhu C; Ni G
    Chin Med J (Engl); 2001 Apr; 114(4):407-9. PubMed ID: 11780465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA type is not indicative for the effect of thymectomy in myasthenia gravis.
    Kuks JB; Lems SP; Oosterhuis HJ
    J Neuroimmunol; 1992 Feb; 36(2-3):217-24. PubMed ID: 1732282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-DR and -DQ gene polymorphism in West Africans is twice as extensive as in north European Caucasians: evolutionary implications.
    Olerup O; Troye-Blomberg M; Schreuder GM; Riley EM
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8480-4. PubMed ID: 1681538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DQ restriction fragment length polymorphisms in myasthenia gravis.
    Bell JI; Steinman L; Toyka K; McDevitt HO
    Ann N Y Acad Sci; 1987; 505():382-7. PubMed ID: 2891337
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus.
    Garcia-Ameijeiras A; Gladman DD; Chan JY; Volpé R
    Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and immunological differences between early and late-onset myasthenia gravis in Japan.
    Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Kuwana M; Suzuki N
    J Neuroimmunol; 2011 Jan; 230(1-2):148-52. PubMed ID: 21074862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative serological and molecular study of linear IgA disease and dermatitis herpetiformis.
    Sachs JA; Leonard J; Awad J; McCloskey D; Festenstein H; Hitman GA; Fry L
    Br J Dermatol; 1988 Jun; 118(6):759-64. PubMed ID: 2900020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.